MCAM and COVID-19: Significant changes in levels of plasma EVs in patients with different severity of infections demonstrated participation of red blood cell- and leukocyte-derived vesicles in COVID-19 pathogenesis, which cannot be declared about most investigated endothelial-derived EVs, except CD146+.